Cargando…
Worldwide legislative challenges related to psychoactive drugs
ABSTRACT: The discovery of a “new” psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have wi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455135/ https://www.ncbi.nlm.nih.gov/pubmed/28578694 http://dx.doi.org/10.1186/s40199-017-0180-2 |
_version_ | 1783240990188896256 |
---|---|
author | Negrei, Carolina Galateanu, Bianca Stan, Miriana Balalau, Cristian Dumitru, Mircea Lucian Bogdan Ozcagli, Eren Fenga, Concettina Kovatsi, Leda Fragou, Domniki Tsatsakis, Aristidis |
author_facet | Negrei, Carolina Galateanu, Bianca Stan, Miriana Balalau, Cristian Dumitru, Mircea Lucian Bogdan Ozcagli, Eren Fenga, Concettina Kovatsi, Leda Fragou, Domniki Tsatsakis, Aristidis |
author_sort | Negrei, Carolina |
collection | PubMed |
description | ABSTRACT: The discovery of a “new” psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances. GRAPHICAL ABSTRACT: Current and future laws regarding psychoactive compounds. [Image: see text] |
format | Online Article Text |
id | pubmed-5455135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54551352017-06-06 Worldwide legislative challenges related to psychoactive drugs Negrei, Carolina Galateanu, Bianca Stan, Miriana Balalau, Cristian Dumitru, Mircea Lucian Bogdan Ozcagli, Eren Fenga, Concettina Kovatsi, Leda Fragou, Domniki Tsatsakis, Aristidis Daru Review Article ABSTRACT: The discovery of a “new” psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances. GRAPHICAL ABSTRACT: Current and future laws regarding psychoactive compounds. [Image: see text] BioMed Central 2017-06-02 /pmc/articles/PMC5455135/ /pubmed/28578694 http://dx.doi.org/10.1186/s40199-017-0180-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Article Negrei, Carolina Galateanu, Bianca Stan, Miriana Balalau, Cristian Dumitru, Mircea Lucian Bogdan Ozcagli, Eren Fenga, Concettina Kovatsi, Leda Fragou, Domniki Tsatsakis, Aristidis Worldwide legislative challenges related to psychoactive drugs |
title | Worldwide legislative challenges related to psychoactive drugs |
title_full | Worldwide legislative challenges related to psychoactive drugs |
title_fullStr | Worldwide legislative challenges related to psychoactive drugs |
title_full_unstemmed | Worldwide legislative challenges related to psychoactive drugs |
title_short | Worldwide legislative challenges related to psychoactive drugs |
title_sort | worldwide legislative challenges related to psychoactive drugs |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455135/ https://www.ncbi.nlm.nih.gov/pubmed/28578694 http://dx.doi.org/10.1186/s40199-017-0180-2 |
work_keys_str_mv | AT negreicarolina worldwidelegislativechallengesrelatedtopsychoactivedrugs AT galateanubianca worldwidelegislativechallengesrelatedtopsychoactivedrugs AT stanmiriana worldwidelegislativechallengesrelatedtopsychoactivedrugs AT balalaucristian worldwidelegislativechallengesrelatedtopsychoactivedrugs AT dumitrumircealucianbogdan worldwidelegislativechallengesrelatedtopsychoactivedrugs AT ozcaglieren worldwidelegislativechallengesrelatedtopsychoactivedrugs AT fengaconcettina worldwidelegislativechallengesrelatedtopsychoactivedrugs AT kovatsileda worldwidelegislativechallengesrelatedtopsychoactivedrugs AT fragoudomniki worldwidelegislativechallengesrelatedtopsychoactivedrugs AT tsatsakisaristidis worldwidelegislativechallengesrelatedtopsychoactivedrugs |